Shares of the company are trading at $65.70 slightly over the 50 day moving average which is $59.88 and which is a tad above the 200 day moving average of $60.81. The 50 day moving average was up by +9.71% and the 200 day average was up $4.89. (NYSE:USNA) shares saw heavy trading volume with 110K shares changing hands in the last trading session. Shares saw a steep increase in trading volume of 2.29% over the normal average daily volume.
Traders are a little more bearish on USANA Health Sciences, Inc. of late if you take a look at the increase in short interest. The firm had a rise in short interest between September 29, 2017 and October 13, 2017 of 3.01%. Short interest increased from 1,112,273 to 1,145,786 over that period. The short-interest ratio decreased to 14.0 and the short interest percentage is 0.05% as of October 13.
Here is a rundown on some insider market activity for USANA Health Sciences, Inc. (NYSE:USNA). Director Myron W. Wentz sold 40,000 shares at a price of $57.55 on October 3rd. That brings Wentz’s holdings to $699,240,442 per an SEC filing yesterday. Myron W. Wentz, Director reported the sale of 28,788 shares of USNA stock. The shares were sold on September 15th for an average price of $57.19. Wentz now owns $697,153,992 of the stock according to the SEC filing.
Director Myron W. Wentz disclosed the sale of 79,294 shares. The shares sold for $57.60. The Director now owns $703,810,138 of the stock per the Form 4 SEC filing.
Additionally, here are a few investment firms who have increased or decreased their stake in (USNA). Trust CO Of Vermont bolstered its stake by buying 3,900 shares an increase of 482.7% as of 09/30/2017. Trust CO Of Vermont currently owns 4,708 shares with a value of $272,000. The value of the position overall is up by 423.1%. Nationwide Fund Advisors divested its ownership by selling 190 shares a decrease of 2.9%. Nationwide Fund Advisors now controls 6,399 shares valued at $369,000. The total value of its holdings decreased 12.6%.
First Trust Advisors Lp reduced its position by shedding 4,102 shares a decrease of 19.0% in the quarter. First Trust Advisors Lp claims 17,436 shares worth $1,006,000. The value of the position overall is down by 27.2%. Aperio Group, LLC expanded its investment by buying 1,653 shares an increase of 14.4% from 06/30/2017 to 09/30/2017. Aperio Group, LLC owns 13,138 shares with a value of $758,000. The total value of its holdings increased 3.0%.
USANA Health Sciences, Inc.’s P/E ratio is 17.06 and market cap is 1.61B. In the last earnings report the EPS was $3.85 and is estimated to be $3.92 for the current year with 24,445,000 shares presently outstanding. Analysts expect next quarter’s EPS to be $1.04 and the next full year EPS is projected to be $4.34.
USANA Health Sciences, Inc., launched on July 20, 1992, develops and manufactures science-based nutritional and personal care products. The Company has operations in 20 markets across the world. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. The Business’s product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. The Business’s USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of 13 months of age. The USANA Nutritionals Essentials products include USANA CellSentials and HealthPak 100. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. These products support needs, such as cardiovascular health, skeletal/structural health and digestive health, and are intended to be used in conjunction with the Essentials. The Optimizers products include Proflavanol, CoQuinone 30 and BiOmega-3..